Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains

Neurobiology of Disease

Volumn 45, Issue 3, 2012, Pages 930-938

  Singh, Ajay ^a   Qing, Liuting ^a   Kong, Qingzhong ^a   Singh, Neena ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggregation; Ferritin; Iron imbalance; Neurotoxicity; Prions

Indexed keywords

FERRITIN; PRION PROTEIN; PRION SCRAPIE PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TOXICITY; CELL DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IRON DEFICIENCY; IRON TRANSPORT; LUMBAR SPINAL CORD; NERVE CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN PURIFICATION; SCRAPIE; SPORADIC CREUTZFELDT JAKOB DISEASE; TISSUE HOMOGENATE; UPREGULATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; DEMENTIA; DISEASE MODELS, ANIMAL; FEMALE; FERRITINS; GLIAL FIBRILLARY ACIDIC PROTEIN; HOT TEMPERATURE; HUMANS; IRON; IRON ISOTOPES; LIVER; MALE; MICE; MIDDLE AGED; PRIONS; SPINAL CORD; TIME FACTORS; TRANSFERRIN;

EID: 84856574059     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.12.012     Document Type: Article

References (56)

1. Adlard P.A., Bush A.I. Metals and Alzheimer's disease. J. Alzheimers Dis. 2006, 10:145-163.
2. Aguzzi A., Calella A.M. Prions: protein aggregation and infectious diseases. Physiol. Rev. 2009, 89:1105-1152.
3. Altamura S., Muckenthaler M.U. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J. Alzheimers Dis. 2009, 16:879-895.
4. Sc levels. J. Virol. 2007, 81:689-697.
5. Sc in cells and infectious brain homogenate by redox-iron: implications for prion replication and disease pathogenesis. Mol. Biol. Cell 2007, 18:3302-3312.
6. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17:5-17.
7. Bonda D.J., Lee H.G., Blair J.A., Zhu X., Perry G., Smith M.A. Role of metal dyshomeostasis in Alzheimer's disease. Metallomics 2011, 3:267-270.
8. Castilla J., Saa P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121:195-206.
9. Caughey B., Baron G.S., Chesebro B., Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 2009, 78:177-204.
10. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005, 308:1435-1439.
11. Choi C.J., Kanthasamy A., Anantharam V., Kanthasamy A.G. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 2006, 27:777-787.
12. Choi C.J., Anantharam V., Saetveit N.J., Houk R.S., Kanthasamy A., Kanthasamy A.G. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicol. Sci. 2007, 98:495-509.
13. Choi C.J., Anantharam V., Martin D.P., Nicholson E.M., Richt J.A., Kanthasamy A., Kanthasamy A.G. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicol. Sci. 2010, 115:535-546.
14. Das D., Luo X., Singh A., Gu Y., Ghosh S., Mukhopadhyay C.K., Chen S.G., Sy M.S., Kong Q., Singh N. Paradoxical role of prion protein aggregates in redox-iron induced toxicity. PLoS One 2010, 5:e11420.
15. Deleault N.R., Harris B.T., Rees J.R., Supattapone S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9741-9746.
16. Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., Cho H.H., Galatis D., Moir R.D., Masters C.L., McLean C., Tanzi R.E., Cappai R., Barnham K.J., Ciccotosto G.D., Rogers J.T., Bush A.I. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010, 142:857-867.
17. Fernaeus S., Land T. Increased iron-induced oxidative stress and toxicity in scrapie-infected neuroblastoma cells. Neurosci. Lett. 2005, 382:133-136.
18. Fernaeus S., Halldin J., Bedecs K., Land T. Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res. Mol. Brain Res. 2005, 133:266-273.
19. Goodbrand I.A., Ironside J.W., Nicolson D., Bell J.E. Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease. Neurosci. Lett. 1995, 183:127-130.
20. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996, 1275:161-203.
21. Heiseke A., Aguib Y., Schatzl H.M. Autophagy, prion infection and their mutual interactions. Curr. Issues Mol. Biol. 2010, 12:87-97.
22. Hesketh S., Sassoon J., Knight R., Brown D.R. Elevated manganese levels in blood and CNS in human prion disease. Mol. Cell. Neurosci. 2008, 37:590-598.
23. Hur K., Kim J.I., Choi S.I., Choi E.K., Carp R.I., Kim Y.S. The pathogenic mechanisms of prion diseases. Mech. Ageing Dev. 2002, 123:1637-1647.
24. Hwang D., Lee I.Y., Yoo H., Gehlenborg N., Cho J.H., Petritis B., Baxter D., Pitstick R., Young R., Spicer D., Price N.D., Hohmann J.G., Dearmond S.J., Carlson G.A., Hood L.E. A systems approach to prion disease. Mol. Syst. Biol. 2009, 5:252.
25. Irjala K., Suonpää J., Laurent B. Identification of CSF leakage by immunofixation. Arch. Otolaryngol. 1979, 105:447-448.
26. Iwasaki Y., Yoshida M., Hashizume Y., Kitamoto T., Sobue G. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2005, 110:490-500.
27. Johnstone D., Milward E.A. Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease. J. Neurochem. 2010, 113:1387-1402.
28. Kell D. A systems biologist ponders how disparate ideas can sometimes come together beautifully. Nature 2009, 460:6.
29. Kell D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 2010, 84:825-889.
30. Kim B.H., Jun Y.C., Jin J.K., Kim J.I., Kim N.H., Leibold E.A., Connor J.R., Choi E.K., Carp R.I., Kim Y.S. Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice. Neurosci. Lett. 2007, 422:158-163.
31. Kontoghiorghes G.J., Chambers S.A., Victor Hoffbrand A.V. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators. Biochem. J. 1987, 241:87-92.
32. Koorts A.M., Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch. Physiol. Biochem. 2007, 113:30-54.
33. Lee D.W., Andersen J.K. Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?. J. Neurochem. 2010, 112:332-339.
34. Madsen E., Gitlin J.D. Copper and iron disorders of the brain. Annu. Rev. Neurosci. 2007, 30:317-337.
35. Mallucci G.R., White M.D., Farmer M., Dickinson A., Khatun H., Powell A.D., Brandner S., Jefferys J.G., Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007, 53:325-335.
36. Martin D.P., Anantharam V., Jin H., Witte T., Houk R., Kanthasamy A., Kanthasamy A.G. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology 2011, 10.1016/j.neuro.2011.07.008.
37. Meurman O.H., Irjala K., Suonpää J., Laurent B. A new method for the identification of cerebrospinal fluid leakage. Acta Otolaryngol. 1979, 87:366-369.
38. Miller M.B., Supattapone S. Superparamagnetic nanoparticle capture of prions for amplification. J. Virol. 2011, 85:2813-2817.
39. Molina-Holgado F., Hider R.C., Gaeta A., Williams R., Francis P. Metals ions and neurodegeneration. Biometals 2007, 20:639-654.
40. Moore R.A., Timmes A., Wilmarth P.A., Priola S.A. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics 2010, 10:2858-2869.
41. Petersen R.B., Siedlak S.L., Lee H.G., Kim Y.S., Nunomura A., Tagliavini F., Ghetti B., Cras P., Moreira P.I., Castellani R.J., Guentchev M., Budka H., Ironside J.W., Gambetti P., Smith M.A., Perry G. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. (Berl.) 2005, 110:232-238.
42. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13363-13383.
43. Quintana C., Gutiérrez L. Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?. Biochim. Biophys. Acta 2010, 1800:770-782.
44. Radford H.E., Mallucci G.R. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons. Curr. Issues Mol. Biol. 2010, 12:119-127.
45. Rebouche C.J., Wilcox C.L., Widness J.A. Microanalysis of non-heme iron in animal tissues. J. Biochem. Biophys. Methods 2004, 58:239-251.
46. Resenberger U.K., Winklhofer K.F., Tatzelt J. Neuroprotective and neurotoxic signaling by the prion protein. Top. Curr. Chem. 2011, 305:101-119.
47. Rouault T.A., Cooperman S. Brain iron metabolism. Semin. Pediatr. Neurol. 2006, 13:142-148.
48. Saunders G.C., Horigan V., Tout A.C., Windl O. Identification of a proteinase K resistant protein for use as an internal positive control marker in PrP Western blotting. Res. Vet. Sci. 2007, 83:157-164.
49. Singh A., Isaac A.O., Luo X., Mohan M.L., Cohen M.L., Chen F., Kong Q., Bartz J., Singh N. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog. 2009, 5:e1000336.
50. Singh A., Mohan M.L., Isaac A.O., Luo X., Singh N. Prion protein modulates cellular iron metabolism: implications for prion disease pathogenesis. PLoS One 2009, 4:e4468.
51. Singh A., Kong Q., Luo X., Petersen R.B., Meyerson H., Singh N. Prion protein knock-out mice show altered iron metabolism: a functional role for PrP in iron metabolism. PLoS One 2009, 4:e6115.
52. Singh N., Singh A., Das D., Mohan M.L. Redox control of prion and disease pathogenesis. Antioxid. Redox Signal. 2010, 12:1271-1294.
53. Singh A., Beveridge A., Gambetti P., Singh N. CSF transferrin is down-regulated in sCJD: a potential pre-mortem diagnostic test for prion disorders. PLoS One 2011, 6:e16804.
54. Smith M.A., Zhu X., Tabaton M., Liu G., McKeel D.W., Cohen M.L., Wang X., Siedlak S.L., Dwyer B.E., Hayashi T., Nakamura M., Nunomura A., Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 2010, 19:363-372.
55. Soto C., Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol. Med. 2010, 17:14-24.
56. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327:1132-1135.